BENGALURU, May 15 (Reuters) - Indian pharmaceutical company Mankind Pharma (MNKI.NS), opens new tab posted a more than 65% rise in its fourth-quarter profit on Wednesday, helped by strong domestic ...
Brothers Ramesh (left) and Rajeev Juneja at Mankind Pharma's headquarters in Delhi. Mankind Pharma—owned by Indian billionaire brothers Ramesh and Rajeev Juneja— has agreed to buy Bharat Serums and ...
Revenue (Q3 FY26): INR3,567 crores, up 11.5% year-on-year. Revenue (9 months FY26): INR10,835 crores, up 18.7% year-on-year. Adjusted EBITDA Margin (Q3 FY26): 25.9%. Adjusted EBITDA Margin (9 months ...
Mankind Pharma Ltd. remains confident that the rise of GLP-1 therapies will not materially impact its anti-diabetic portfolio, highlighting continued strength across both acute and chronic segments.
BENGALURU, Jan 31 (Reuters) - Mankind Pharma (MNKI.NS), opens new tab, one of India's leading condom makers, posted a bigger-than-expected rise in third-quarter profit on Wednesday, driven by strong ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results